Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

298 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. Poser CM, et al. Among authors: tourtellotte ww. Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302. Ann Neurol. 1983. PMID: 6847134 No abstract available.
A STUDY OF THE BLOOD-CEREBROSPINAL FLUID-BRAIN BARRIER IN MULTIPLE SCLEROSIS. I. BLOOD-CEREBROSPINAL FLUID BARRIER TO SODIUM BROMIDE.
HAERER AF, TOURTELLOTTE WW, RICHARD KA, GUSTAFSON GM, BRYAN ER. HAERER AF, et al. Among authors: tourtellotte ww. Neurology. 1964 Apr;14:345-54. doi: 10.1212/wnl.14.4.345. Neurology. 1964. PMID: 14138681 No abstract available.
Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.
Myers LW, Ellison GW, Merrill JE, El Hajjar A, St Pierre B, Hijazin M, Leake BD, Bentson JR, Nuwer MR, Tourtellotte WW, Davis P, Granger D, Fahey JL. Myers LW, et al. Among authors: tourtellotte ww. Neurology. 1998 Nov;51(5):1483-6. doi: 10.1212/wnl.51.5.1483. Neurology. 1998. PMID: 9818891 Clinical Trial.
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Ohman S, Racke MK, Sharief M, Sindic CJ, Sellebjerg F, Tourtellotte WW. Freedman MS, et al. Among authors: tourtellotte ww. Arch Neurol. 2005 Jun;62(6):865-70. doi: 10.1001/archneur.62.6.865. Arch Neurol. 2005. PMID: 15956157
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group.
Ellison GW, Myers LW, Leake BD, Mickey MR, Ke D, Syndulko K, Tourtellotte WW. Ellison GW, et al. Among authors: tourtellotte ww. Ann Neurol. 1994;36 Suppl:S108-12. doi: 10.1002/ana.410360725. Ann Neurol. 1994. PMID: 8017868
A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
Tourtellotte WW, Syndulko K, Baumhefner RW, Shapshak P, Osborne M. Tourtellotte WW, et al. Neurology. 1988 Jul;38(7 Suppl 2):83-6. Neurology. 1988. PMID: 3386848 No abstract available.
Copolymer 1 as therapy for multiple sclerosis: the cons.
Baumhefner RW, Tourtellotte WW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G. Baumhefner RW, et al. Among authors: tourtellotte ww. Neurology. 1988 Jul;38(7 Suppl 2):69-72. Neurology. 1988. PMID: 3386845 Clinical Trial.
Variability on serial testing of visual evoked potentials in patients with multiple sclerosis.
Cohen SN, Syndulko K, Hansch E, Tourtellotte WW, Potvin AR. Cohen SN, et al. Among authors: tourtellotte ww. Adv Neurol. 1982;32:559-65. Adv Neurol. 1982. PMID: 7054985 No abstract available.
Improved diagnostic yield in evaluation of multiple sclerosis using critical frequency of photic driving with pattern reversal-evoked potentials.
Cohen SN, Syndulko K, Hansch EC, Gilden E, Phillips K, Tourtellotte WW, Potvin AR. Cohen SN, et al. Among authors: tourtellotte ww. Adv Neurol. 1982;32:459-62. Adv Neurol. 1982. PMID: 7054970 No abstract available.
Critical frequency of photic driving in the diagnosis of multiple sclerosis. A comparison to pattern evoked responses.
Cohen SN, Syndulko K, Tourtellotte WW, Potvin AR. Cohen SN, et al. Among authors: tourtellotte ww. Arch Neurol. 1980 Feb;37(2):80-3. doi: 10.1001/archneur.1980.00500510038005. Arch Neurol. 1980. PMID: 7356412
298 results
Jump to page
Feedback